Leases (Notes)

12 Months Ended

Jan. 03, 2021

Disclosure Text Block [Abstract]

Leases [Text Block]

Leases

Lessee Disclosures

The Company leases certain property and equipment under operating and finance leases. The Company's leases have remaining lease terms of less than 1 year to 30 years, some of which include options to extend the lease for up to 5 years, and some of which include options to terminate the lease within 1 year. Finance leases are not material to the Company.

The components of lease expense were as follows:

	January 3, 2021		December 29, 2019
	(In thousands)
Lease Cost:
Operating lease cost	$	56,977	$	61,205

Supplemental cash flow information related to leases was as follows:

	January 3, 2021		December 29, 2019
	(In thousands)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	47,427	$	50,155

Supplemental balance sheet information related to leases was as follows:

	January 3, 2021		December 29, 2019
	(In thousands, except lease term and discount rate)
Operating Leases:
Operating lease right-of-use assets	$	207,236	$	167,276
Operating lease liabilities included in Accrued expenses and other current liabilities	$	40,330	$	36,573
Operating lease liabilities	188,402		146,399
Total operating liabilities	$	228,732	$	182,972
Weighted Average Remaining Lease Term in Years
Operating leases	8.1
Weighted Average Remaining Discount Rate
Operating leases	2.9%

Maturities of operating lease liabilities as of January 3, 2021 were as follows:

	(In thousands)
2021	$	48,986
2022	40,097
2023	30,044
2024	26,667
2025	24,847
2026 and thereafter	90,518
Total lease payments	261,159
Less imputed interest	(32,427)
Total	$	228,732

Lessor Disclosures

Certain of the Company's contracts require that it place its instrument at the customer's site and sell reagents to the customer. As the predominant component in these contracts are the sales of reagents, the Company accounts for the combined component under ASC 606 only when both of the following criteria are met: 1) the timing and pattern of transfer of the non-lease component or components and associated lease component are the same; and 2) the lease component, if accounted for separately, would be classified as an operating lease. When only one of the criteria is met, the Company accounts for the non-lease component under ASC 606 and the lease component under ASC 842. Profit or loss, interest income and aggregate net investment in sales-type leases that did not qualify for the practical expedient are not material to the Company.

Leases of Lessor Disclosure [Text Block]

Lessor DisclosuresCertain of the Company's contracts require that it place its instrument at the customer's site and sell reagents to the customer. As the predominant component in these contracts are the sales of reagents, the Company accounts for the combined component under ASC 606 only when both of the following criteria are met: 1) the timing and pattern of transfer of the non-lease component or components and associated lease component are the same; and 2) the lease component, if accounted for separately, would be classified as an operating lease. When only one of the criteria is met, the Company accounts for the non-lease component under ASC 606 and the lease component under ASC 842. Profit or loss, interest income and aggregate net investment in sales-type leases that did not qualify for the practical expedient are not material to the Company.